Search:
 
BioEnterprise
Recent News

» Clayton Dubilier & Goldman Sachs to Acquire Edgepark Medical for $850 Million
» Great Lakes Pharmaceuticals raises $3.1 Million
» AxioMed Raises $14.5 Million
» Syncro Raises Additional $800,000
» Factory Jobs Return, but Employers Find Skills Shortage
» Two Healthcare Companies Announce Major Expansions
» Ohioans vote for their futures, extend Third Frontier program



Commercialized Products & Services


Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More




Exit Companies



Since 2002, 21 Cleveland-area health care companies have had successful exits.

» View More




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
Companies > Clinical
print
Navotek is developing proprietary RealTrack intra-body tracking technology, a patient positioning and real-time target monitoring system for radiation therapy. Today radiation treatment kills cancer cells, but it often damages healthy tissue as well due to frequent movement of internal organs. Coupling an innovative trackable tracer with a unique sensor technology, the Navotek system is designed to allow physicians to safely and accurately reach their targets in a cost-effective manner.

Funders:
Wanaka Capital Partners, Bridge Investment Fund
 
Copyright © 2010 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999